Table 1 Demographics of the group with valid recordings, and the subgroup randomly selected for additional analysis by M2
From: Inter-rater disagreement in manual scoring of intensive care unit sleep data
Characteristic | Valid recordings (n = 61) | Analysed by M2 (n = 17) | p-value* |
|---|---|---|---|
N (%) | N (%) | ||
Sex | 23 (37.7) | 8 (47.06) | 0.357 |
ICU admission diagnosis | |||
Surgical | 19 (31.15) | 5 (29.41) | 0.859 |
Medical | 42 (68.85) | 12 (70.59) | 0.859 |
12 month mortality | 19 (31.15) | 4 (23.53) | 0.433 |
Median (IQR) | Median (IQR) | ||
|---|---|---|---|
BMI | 26 (23–29) | 28 (24–32) | 0.256 |
Age, years | 60 (52–67) | 63 (52–67) | 0.388 |
Duration of hospital stay, days | 31 (19–55.49) | 21.99 (15.99–43) | 0.573 |
Duration of ICU stay, days | 10.99 (5.51–25.50) | 7.01 (4.01–18.98) | 0.014 |
Duration of recording, hours | 47.74 (17.22) | 46.66 (43–65.89) | 0.248 |
APACHE IV | 69 (47–82) | 74 (61.25–81.25) | 0.098 |
SAPS II | 40 (31–49) | 42 (36–44) | 0.214 |
Mechanical ventilation, days | 7 (1–16) | 5 (1–14) | 0.282 |
Mean (SD) | |||
|---|---|---|---|
Medication dose per day | |||
Benzodiazepines, mg Lorazepam equivalent | 1.55 (4.82) | 2.95 (8.77) | 0.371 |
Opioids, mg Morphine equivalent | 1.80 (3.63) | 0.95 (1.92) | 0.242 |
Propofol 2%, ml | 1.81 (7.27) | 2.96 (10.59) | 0.459 |